IP Library Granted Patent US 12,372,518
Granted Patent B2
US 12,372,518 · App. 18/544,491 · Granted Jul 29, 2025

Method for stabilizing extracellular vesicles

Inventors: Tatsutoshi Inuzuka (Tokyo, JP); Ayako Kurimoto (Tokyo, JP); Yuki Kawasaki (Tokyo, JP)
Assignee: H.U. Group Research Institute G. K.
G01N33/54306
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,372,518
App. No.
18/544,491
Granted
Jul 29, 2025
Kind
B2
Abstract

The present invention provides stabilization of an extracellular vesicle. Specifically, the present invention provides, for example, a method of stabilizing the extracellular vesicle including mixing an extracellular vesicle-containing sample with a saccharide and a chelating agent.

Claims (17)

1. A method of stabilizing an extracellular vesicle, the method comprising:

mixing the extracellular vesicle-containing sample with a first chelating agent, to obtain a first mixture;

separating the first mixture into (i) a liquid portion comprising the first chelating agent and (ii) a precipitation portion comprising the extracellular vesicles;

removing the liquid portion;

recovering the precipitation portion;

mixing the precipitation portion with a second chelating agent in a first solution to obtain a second mixture;

freeze-drying the second mixture to obtain a freeze-dried extracellular vesicle; and

dissolving the freeze-dried extracellular vesicle in a second solution.

2. The method of claim 1 , wherein a concentration of the first chelating agent in the mixing is from 20 to 200 mM.

3. The method of claim 1 , wherein a concentration of the first chelating agent in the mixing is from 40 to 200 mM.

4. The method of claim 1 , wherein a concentration of the first chelating agent in the mixing is from 50 to 200 mM.

5. The method of claim 1 , wherein the mixing the precipitation portion with a second chelating agent in a first solution to obtain a second mixture is carried out by mixing the precipitation portion with the chelating agent in the presence of a saccharide.

6. The method of claim 5 , wherein a concentration of the saccharide in the mixing is from 2.5 to 100 mg/mL.

7. The method according to claim 1 , wherein the extracellular vesicle is an exosome.

8. The method of claim 1 , wherein the extracellular vesicle-containing sample is a body fluid or a culture supernatant.

9. The method of claim 1 , wherein the extracellular vesicle-containing sample is a blood sample.

10. The method of claim 5 , wherein a concentration of the second chelating agent is from 1 to 200 mM per 10 mg/mL of the saccharide.

Assignments (1)
SECURITY INTEREST Recorded Mar 11, 2025
From: MERU HEALTH OY
To: AVIDBANK
Reel/Frame 070477/0721 →
Priority Claims (2)
JP 2017-245603 · Dec 21, 2017 · national
JP 2018-076185 · Apr 11, 2018 · national
Continuity (2)
Division 16955553
Related Publication 20240118270A1 · Apr 11, 2024
References Cited (18)
US 11614388B2 · Inuzuka · 2023 [cited by examiner]
US 20150125864A1 · Kang et al. · 2015 [cited by applicant]
US 20190060367A1 · Zhang et al. · 2019 [cited by applicant]
US 20190231694A1 · Lim · 2019 [cited by applicant]
US 20190336539A1 · Wallace et al. · 2019 [cited by applicant]
US 20190391163A1 · Stemmer et al. · 2019 [cited by applicant]
US 20230194399A1 · Inuzuka · 2023 [cited by examiner]
WO WO2016197196A1 · 2016 [cited by applicant]
WO WO2017139795 · 2017 [cited by examiner]
WO WO2017152035A1 · 2017 [cited by applicant]
WO WO2017194499A1 · 2017 [cited by applicant]
WO WO2018070939A1 · 2018 [cited by applicant]
Kurimoto et al., “Enhanced recovery of CD9-positive extracellular vesicles from human specimens by chelating reagent, ” bioRxiv, 2020, Jun. 2020; pp. 1-15. [cited by examiner]
Fuhrmann, G., et al. “Stability of extracellular vesicles during lyophilization-implication for their pharmaceutical use,” Journal of Extracellular Vesicles, The 2nd United Kingdom Extracellular VesicleForum Meeting Abs… [cited by applicant]
International Search Report issued on Mar. 26, 2019 in PCT/JP2018/047098 filed on Dec. 20, 2018 citing documents AA, AO and AW therein, 1 page. [cited by applicant]
Extended European Search Report issued Oct. 26, 2021 in European Patent Application No. 18892197.7, citing documents AO through AQ and AX therein, 9 pages. [cited by applicant]
Bosch, S., et al., “Trehalose prevents aggregation of exosomes and cryodamage”, Scientific Reports, vol. 6, No. 1, Nov. 8, 2016, XP055500173, pp. 1-11. [cited by applicant]
Aisen et al., “Effect of Trehalose and EDTA on Cryoprotective Action of Ram Semen Diluents”, [cited by applicant]